Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
City Therapeutics Inc. logo

City Therapeutics Inc. (CTY) Stock Ticker

NASDAQ: CTY · Healthcare · Biotechnology
$22.14+2.26%
USD · as of 2026-10-30 · market cap $215.2M
Open CTY in TickrDownload for iPhone

CTY right now

Newly listed this month.
From Tickr's live models · 2026-10-30. Not investment advice.

Market factors today

Tickr 500 vs S&P 500-0.40%+0.1% MTD
Momentum L/S-2.28%-10.1% MTD
High-beta momo L/S-2.20%-19.4% MTD
Rate sensitivity L/S+0.45%-8.7% MTD
Oil sensitivity L/S-0.44%+14.9% MTD
Unprofitable tech-1.83%-0.5% MTD

Unlock the full CTY picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on CTY
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About City Therapeutics Inc.

City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets. Its R&D pipeline includes programs addressing thromboembolic diseases (targeting Factor XI), Stargardt disease (targeting RBP4), and other hepatic, ocular, and CNS conditions. Lead candidates include CITY-FXI, designed to prevent blood clots with reduced bleeding risk, and CITY-RBP4, aimed at slowing or halting vision loss in Stargardt disease. The company was founded by Ari Nowacek, John M. Maraganore. Andrew C. Orth has been the CEO of the company since 2025.

CTY stock facts

Ticker symbolCTY
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$215.2M
CEOAndrew C. Orth
Employees75
HeadquartersCambridge, MA, US
IPO date2026-10-16
Websitewww.citytx.com

What you can see for CTY on Tickr

Live CTY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CTY report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for City Therapeutics Inc.?

The ticker symbol for City Therapeutics Inc. is CTY, listed on the NASDAQ.

What is CTY?

City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets. Its R&D pipeline…

HomeExploreMarketLists
All pages